|
Abstracts for E-posters/oral presentations at
CCPSL Annual Academic Sessions 2022 will be
entertained from case reports/ case series and
original research/audits based on topics related
to Clinical Biochemistry/Chemical Pathology. All
abstracts must be in accordance with the
following guidelines. Abstracts can be submitted
under two categories. (Either oral presentation
or E-poster category and E-poster only category)
Final decision of acceptance/rejection of
abstracts will be made by the Abstract Review
Committee.
Submission
Timeline
|
Abstract
Submission
Opens |
:
21st March
2022 |
|
Abstract
Submission
Deadline |
:
15th
May
2022 at
12 noon |
|
Author
Notification
of
Acceptance
|
:
10th
June
2022 |
Guidelines
1.The presenting
author is
required to
register for the
CCPSL Annual
Academic
Sessions 2022
following
acceptance of
the abstract by
the Review
Committee.
2. Any late
submissions
after the given
deadline will
not be
entertained by
the Abstract
Review
Committee.
3. Please ensure
that you provide
a valid email
address and a
contact number
of the
presenting
author.
4. No payments
should be done
to submit an
abstract.
5. There is no
limit to the
number of
abstracts that
one author can
submit.
6. Abstracts
should be
thoroughly
checked for
correct spelling
and grammar
before
finalizing the
submission.
7. Abstracts
will be reviewed
by the Review
Committee to
match the
criteria:
- Originality and interest
- Structure and clarity
- Scientific validity
- Potential significance
Common
Abstract Format
|
Word
limit in
thebody
of the
abstract
(excludes
title,
authors,
affiliations
and
keywords) |
300
words.
Abstracts
over
this
limit
will be
asked to
be
revised
to the
word
limit. |
|
Font
type |
Times
New
Roman |
|
Font
size |
12
point |
|
Line
spacing |
1.5 |
|
Title |
Maximum
character
limit -
150
characters
without
spaces
Font -
Bold,
Times
New
Roman,
12 point
Justification
- Left
justify
Abbreviations
must not
be used
in the
title. |
|
Author(s) |
List
of the
names of
all
authors
should
be
included
below
the
title.
-
Surname
followed
by
Initials.
Eg:
Silva JM,
Perera
TH
-
No
prefixes
(e.g.
Dr/
Prof)
should
be
included
in the
author's
name
-
Name of
the
presenting
author
should
be
bolded
and
underlined.
Only the
nominated
presenting
author
should
present
the
poster
presentation
and if
selected,
the oral
presentation.
-
Include
the name
of the
principal
supervisor
at the
end of
the
list.
-
Each
author's
affiliation
should
be
included
following
the list
of names
of all
authors.
-
If more
than one
author
and
address,
insert a
superscript
number
at the
end of
the
initials
before
the
comma.
(for
each
author)
-
Affiliations
should
be
proceeded
by the
superscript
-
Email
address
of the
corresponding
author
should
be
included
below
the
affiliations.
-
Left
justify
Eg:
Silva JM1
, Perera
TH2
1Department
of
Biochemistry,
Faculty
of
Medicine,
University
of
Kelaniya,
Sri
Lanka
2Department
of
Chemical
Pathology,
Colombo
North
Teaching
Hospital,
Sri
Lanka
Silva.jm@gmail.com
|
8. Following are not allowed.
a. References
b. Tables and figures
9. Use of brand/company names should be done in
moderation.
E.g. Brand/company names may be mentioned in
studies of analytical performance of a specific
analyser (Establishing reference range for
creatinine on "Brand X 459" assay)
10. Use abbreviations with restraint. Terms must
be spelt fully the first time they appear.
Abstract Submission
Categories
|
Original
Research/Audits |
| |
The
abstract
should
be
submitted
in the
following
format.
| 1. Title and Author Information |
| |
The title should summarize the abstract and convince the reviewer of the relevance and innovativeness of the work. |
| 2. Introduction and objectives |
| |
The introduction should provide a concise overview of the problem addressed by the research, what remains unknown and how your research would fill the gaps in the knowledge. |
| 3. Methods |
| |
Following areas shall be specifically be (remove) mentioned.
a. Study design
b. Study setting
c. Number of subjects enrolled in the study and any inclusion/exclusion criteria when applicable
d. A description of the intervention (when applicable)
e. A list of the outcome variables and how they were measured
f. Statistical methods used to analyze the data |
| 4. Results |
| |
This should include a description of the subjects that were included and excluded from the study, frequencies of most important outcome variables, any comparisons of the outcome variables between various subgroups within the study (treated vs. untreated, young vs. old, male vs. female, and so forth). Numerical results should include standard deviations, 95% confidence limits and the level of statistical significance. |
| 5. Conclusions |
| |
State concisely what can be concluded and its implications. The conclusions must be supported by the data presented in the abstract. Any unsubstantiated personal opinion should not be included. The generalizability of the results to populations other than that of studied and the weaknesses of the study should be addressed where applicable. |
| 6. Key words: 2-5 key words
|
|
|
Case
report/Case
Series |
| |
A case
report
should
be
submitted
in the
following
format.
| 1. Title and Author Information |
| |
Key elements of the case should be mentioned in the title and might include presenting symptoms/ diagnosis/ intervention/ outcome. The phrase "Case report" should be present in the title. |
| 2. Introduction |
| |
A brief summary of the background and the context of the case report. |
| 3. Case presentation |
| |
a. Presenting concerns and important clinical findings of the patient
b. Diagnostic focus and assessment
i. Diagnostic results
ii. Diagnostic challenges
iii. Relevant prognostic characteristics
c. Interventions, follow-up and outcomes |
| 4. Discussion and conclusions |
| |
The strengths and limitations associated with the case report, how conclusions were arrived at and the applicability of results to other patients should be summarized under this section. A "Take away" message from the case report should be mentioned if applicable.
|
| 5. Key words:2-5 key words |
|
|
